ACTRN12614001198617进行中（未招募）4 期
Insulin pump therapy (Medtronic Veo) for adolescents aged 14 to 18 years with type 1 diabetes and poor glycaemic control (HbA1c greater than 10% for the previous 6 months) , a 12 month pilot study investigating the effect on HbA1c.
Martin de Bock0 个研究点目标入组 10 人开始时间: 2014年11月14日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 14 Years 至 18 Years（—）
- 性别
- All
入选标准
- •1. Age 14 - 18 years with type 1 diabetes
- •2. Duration of diabetes at least 12 months
- •3. Insulin pump therapy naive
- •4. HbA1C>10% for the preceding 6 months
排除标准
- •1. Pregnancy
- •2. Any additional condition(s) that in the investigator’s opinion would warrant exclusion from the study or prevent the subject from completing the study
研究者
相似试验
已完成
不适用
eonatal Insulin Replacement Therapy in Europeutritional, Metabolic, Endocrine: HyperglycaemiaNutritional, Metabolic, EndocrineHyperglycaemiaISRCTN78428828Cambridge University Hospitals NHS Foundation Trust (UK)500
尚未招募
不适用
Insulin Pumps at Diagnosis (IPAD) in children studyType 1 DiabetesACTRN12622000500752Dr Stephanie Johnson80
已完成
不适用
Sensing With Insulin Pump Therapy to Control HbA1c10018424diabetesdiabetes mellitusNL-OMON31759Medtronic B.V.20
尚未招募
不适用
Comparison of continuous versus intermittent administration of insulin for the treatment of diabetic ketoacidosis in childreCTRI/2019/08/020687JIPMER
已完成
不适用
Pilot Study Assessing Insulin Pump Therapy in Type 2 DiabetesType 2 DiabetesNCT00922649Animas Corporation58